Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
09/2014
09/25/2014WO2014150600A2 Modified toxins
09/25/2014WO2014150596A1 Compositions for treating skin disorders
09/25/2014WO2014150314A1 Therapeutic uses for vegfr1 antibodies
09/25/2014WO2014150150A1 Enhanced expression of picornavirus proteins
09/25/2014WO2014149425A1 Methods for treating psoriasis using an anti-il-23 antibody
09/25/2014WO2014148738A1 Novel korean-type porcine reproductive and respiratory syndrome (prrs) virus
09/25/2014WO2014148572A1 Cell metastasis or invasion inhibitor
09/25/2014WO2014147503A2 Anti-bag3 antibodies for therapeutic use
09/25/2014WO2014147131A1 Allergen preparation
09/25/2014WO2014147044A1 Method of treatment
09/25/2014WO2014147001A1 Vaccine to protect a ruminant against pneumonia caused by mannheimia haemolytica
09/25/2014WO2014146778A1 Therapy involving antibodies against claudin 18.2 for treatment of cancer
09/25/2014WO2014146672A1 Therapy involving antibodies against claudin 18.2 for treatment of cancer
09/25/2014WO2014146663A1 Vaccines against chlamydia sp.
09/25/2014WO2014146603A1 Pasteurella multocida toxin recombinant protein and use thereof
09/25/2014WO2014146575A1 Antibodies and methods for treating estrogen receptor-associated diseases
09/25/2014WO2014146487A1 Anti-cell surface ectopic expression monoclonal antibody, preparation method and use thereof
09/25/2014US20140288267 Compositions and methods for modulating rsv infection and immunity
09/25/2014US20140287476 Vibrio cholerae 0139 conjugate vaccines
09/25/2014US20140287043 Compositions and methods for stabilization of active agents
09/25/2014US20140287029 Immunogenic epitopes of ngep antigen
09/25/2014US20140287024 Nanoparticle-based delivery system with oxidized phospholipids as targeting ligands for the prevention, diagnosis and treatment of atherosclerosis
09/25/2014US20140287022 Liposomal formulations
09/25/2014US20140287003 Pharmaceutical formulation for reducing frequency of urination and method of use thereof
09/25/2014US20140286999 Vaccine preparation containing trifunctional antibodies with antigen immunogenicity enhancer properties
09/25/2014US20140286997 Arabinogalactan for enhancing the adaptive immune response
09/25/2014US20140286996 Modified Gram-Negative Bacteria For Use As Vaccines
09/25/2014US20140286994 Norovirus vaccine formulations
09/25/2014US20140286993 Immune methods against influenza viruses and combinatorial vaccines thereof
09/25/2014US20140286992 Influenza virus-like particle (vlp) compositions
09/25/2014US20140286991 Combined cell based gp96-ig-siv/hiv, recombinant gp120 protein vaccination for protection from siv/hiv
09/25/2014US20140286988 Hydrazino 1h-imidazoquinolin-4-amines and conjugates made therefrom
09/25/2014US20140286984 Compositions and Methods for the Treatment or Prevention of Hepatitis B Virus Infection
09/25/2014US20140286981 Broadly reactive mosaic peptide for influenza vaccine
09/25/2014US20140286978 Cytotoxic t lymphocyte inducer
09/25/2014US20140286977 Protein F - A Novel Haemophilus Influenzae Adhesin with Laminin and Vitronectin binding Properties
09/25/2014US20140286975 Methods and composition related to th-1 dendritic cells
09/25/2014US20140286973 Chimeric antigen receptor specific for folate receptor beta
09/25/2014US20140286972 Hypoallergenic chimeric proteins belonging to the lipid transfer family of parietaria judaica for use in the treatment of allergies
09/25/2014US20140286971 Single nucleotide polymorphisms (snp) and association with resistance to immune tolerance induction
09/25/2014US20140286966 Methods and compositions for the treatment of metabolic syndrome, obstructive respiratory disorders, cancer and related diseases
09/25/2014US20140286961 Novel Methods Of Cancer Therapy Targeted Against A Cancer Stem Line
09/25/2014US20140286960 Staphlococcus aureus alpha-hemolysin antibodies
09/25/2014US20140286955 Notch agonists for the treatment of cancer
09/25/2014US20140286954 Tau protease compositions and methods of use
09/25/2014US20140286953 Hepcidin, hepcidin antagonists and methods of use
09/25/2014US20140286951 Met-binding agents and uses thereof
09/25/2014US20140286945 Enzyme inhibitor for cancer treatment
09/25/2014US20140286941 Treatment of tnfalpha related disorders
09/25/2014US20140286940 Treatment of tnfalpha related disorders
09/25/2014US20140286939 Treatment of tnfalpha related disorders
09/25/2014US20140286937 Antibodies binding to an intracellular prl-1 or prl-3 polypeptide
09/25/2014US20140286933 Stable igg4 based binding agent formulations
09/25/2014US20140286897 Compositions and Methods for the Regulation of T Regulatory Cells Using TL1A-Ig Fusion Protein
09/25/2014US20140286871 Bacterial strains expressing methylase genes and uses thereof
09/25/2014US20140286867 Use of tnfalpha inhibitor for treatment of erosive polyarthritis
09/25/2014US20140286861 RS7 Antibodies
09/25/2014US20140286859 Psma antibodies and uses thereof
09/25/2014US20140286858 Method for inducing an immune response for treatment of cancer and autoimmune diseases or conditions
09/24/2014EP2781526A1 Bispecific anti-VEGF/anti-ANG-2 antibodies
09/24/2014EP2780375A1 Binding molecules for bcma and cd3
09/24/2014EP2780374A1 Binding molecules for bcma and cd3
09/24/2014EP2780371A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for regulating the fluid balance in a patient having a chronic or acute disease
09/24/2014EP2780370A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for use in therapy of an acute disease or acute condition of a patient for stabilizing the circulation
09/24/2014EP2780369A1 Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for prevention or reduction of organ dysfunction or organ failure in a patient having a chronic or acute disease or acute condition
09/24/2014EP2780368A1 Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing gdf8 and/or activin a
09/24/2014EP2780366A2 Rsv g protein specific antibodies
09/24/2014EP2780361A1 Conjugates of gm-csf and il-7, compositions and methods related thereto
09/24/2014EP2780351A1 Clostridium difficile lipoteichoic acid and uses thereof
09/24/2014EP2780350A2 Synthetic derivatives of mpl and uses thereof
09/24/2014EP2780038A1 Vaccine comprising a tlr-5 agonist as adjuvant for use in cutaneous immunisation
09/24/2014EP2780037A1 Vaccine
09/24/2014EP2780036A1 Nanoparticle compositions for generation of regulatory t cells and treatment of autoimmune diseases and other chronic inflammatory conditions
09/24/2014EP2780035A1 Immunogenic complexes of polyanionic carbomers and env polypeptides and methods of manufacture and use thereof
09/24/2014EP2780034A1 Heterologous prime-boost immunization using measles virus-based vaccines
09/24/2014EP2780033A1 Methods of treating cancer
09/24/2014EP2780024A1 Tumor vaccination
09/23/2014US8841433 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
09/23/2014US8841432 Shuttle vectors for mycobacteria-escherichia coli and uses thereof
09/23/2014US8841424 Humanized AXL antibodies
09/23/2014US8841423 Monoclonal antibodies specific for oxidized calcium/calmodulin dependent protein kinase II
09/23/2014US8841420 Synthetic peptide constructs for the diagnosis and treatment of periodontis associated with Porphyromonas gingivalis
09/23/2014US8841418 Antibodies that specifically bind to TIM3
09/23/2014US8841417 IL-1 binding proteins
09/23/2014US8841416 Therapeutic nuclease compositions and methods
09/23/2014US8841251 Method for making a homogenous vaccine composition comprising a conjugate of EGF and 64K for the treatment of tumors
09/23/2014US8841120 Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity
09/23/2014US8841110 Animal product free system and process for purifying a botulinum toxin
09/23/2014US8841108 Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins
09/23/2014US8840908 Vaccine composition containing synthetic adjuvant
09/23/2014US8840907 Isolated protein and compositions comprising the protein
09/23/2014US8840906 Methods and compositions related to immunizing against Staphylococcal lung disease and conditions
09/23/2014US8840905 Use of neurotoxin therapy for treatment of urologic and related disorders
09/23/2014US8840904 Compositions and methods for vaccinating against HSV-2
09/23/2014US8840903 Compositions and methods for vaccinating against HSV-2
09/23/2014US8840902 Tumor vaccination involving a humoral immune response against self-proteins
09/23/2014US8840901 YopM as delivery vehicle for cargo molecules and as biological therapeutic for immunomodulation of inflammatory reactions
09/23/2014US8840900 Chimeric bacteriophage lysin with activity against Staphylococci bacteria
09/23/2014US8840899 Use of mTOR inhibitors to enhance T cell immune responses
09/23/2014US8840898 Immunoconjugates targeting syndecan-1 expressing cells and use thereof
1 ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 ... 1823